Zhang Lili, Lin Yuning, Zhang Zhongying, Chen Yuting, Zhong Jinqing
Medical Laboratory Center, Xiamen Humanity Hospital, Xiamen, Fujian, China.
Front Immunol. 2024 Nov 27;15:1444884. doi: 10.3389/fimmu.2024.1444884. eCollection 2024.
Sepsis is a life-threatening syndrome characterized by organ dysfunction, resulting from an uncontrolled or abnormal immune response to infection, which leads to septicemia. It involves a disruption of immune homeostasis, marked by the release of Inflammatory factors and dysfunction of immune cells. Adiponectin is widely recognized as an anti-inflammatory mediator, playing a crucial role in regulating immune cell function and exerting protective effects on tissues and organs. However, the physiological role of adiponectin in septicemia remains unclear due to the condition's association with immune response dysregulation and organ damage. This study focuses on the potential relationship between adiponectin and excessive immune responses, along with organ injury in septicemia. Additionally, we investigate possible explanations for the observed discrepancies in adiponectin levels among critically ill or deceased patients compared to theoretical expectations, aiming to provide valuable insights for clinical diagnostics and therapeutic interventions in sepsis.
脓毒症是一种危及生命的综合征,其特征为器官功能障碍,由对感染的不受控制或异常免疫反应引起,进而导致败血症。它涉及免疫稳态的破坏,其标志是炎症因子的释放和免疫细胞功能障碍。脂联素被广泛认为是一种抗炎介质,在调节免疫细胞功能以及对组织和器官发挥保护作用方面起着关键作用。然而,由于脓毒症与免疫反应失调和器官损伤相关,脂联素在败血症中的生理作用仍不清楚。本研究聚焦于脂联素与过度免疫反应以及败血症中器官损伤之间的潜在关系。此外,我们调查了重症或死亡患者中脂联素水平与理论预期相比存在差异的可能原因,旨在为脓毒症的临床诊断和治疗干预提供有价值的见解。